• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Cardiology

High cardiovascular disease mortality among Native Hawaiian and Pacific Islander adults

byAdrian WongandThomas Su
October 16, 2024
in Cardiology, Chronic Disease, Public Health
Reading Time: 3 mins read
Successful regional implementation of pediatric chest pain algorithm
Share on FacebookShare on Twitter

1. In this cross-sectional study, researchers found that Native Hawaiian and Pacific Islander (NHPI) adults aged 35 years or older died of cardiovascular disease at a rate 50% higher than Asian adults, a group in which they had historically been classified.

2. The age-standardized mortality rate among NHPI adults was the third highest after Black adults and White adults.

Evidence Rating Level: 3 (Average)

Study Rundown: NHPI adults have a high prevalence of chronic disease, thought to have been caused in part by the societal effects of Western colonization of the Pacific region. However, data on cardiovascular disease (CVD) mortality among NHPI adults across the US have been elusive since they have largely been grouped with Asian adults for national studies. This study aimed to examine CVD mortality among NHPI adults aged 35 years or older and compare mortality rates with those among other racial groups in the US, including Asian adults. The researchers found that over 10,000 NHPI adults died of CVD between 2018 and 2022. Over one-third of these deaths occurred in adults younger than 65 years, and the majority occurred in males. The highest risk subgroup within this population was non-Hispanic, single-race NHPI adults, who had a 20% higher CVD ASMR compared with all NHPI adults. After age-standardization, the overall mortality rate was found to be the third highest nationally after Black adults and White adults; further, this rate was 50% higher compared with Asian adults. The generalizability of this study was limited by the potential for misclassification of both cause of death and reported race on death certificates. Nevertheless, this study demonstrated the necessity of considering NHPI adults as a separate group for public health research and surveillance to achieve health equity in this population.

Click to read the study in AIM

Relevant Reading: Cardiometabolic Health Disparities in Native Hawaiians and Other Pacific Islanders

RELATED REPORTS

The mortality in-hospital for patients undergoing elective catheter ablation for atrial fibrillation is low

Mortality in the post-housing period is high among homeless people in Ottawa, Canada

Hematologic inflammatory indices may predict prognosis in younger patients with COVID-19 but not older patients

In-Depth [cross-sectional study]: This observational, cross-sectional study investigated the characteristics of NHPI adults aged 35 years or older who died of CVD in the US between 2018 and 2022 and compared age-standardized mortality rates (ASMRs) among this group with those among other race groups. Mortality data were taken from the National Vital Statistics System (NVSS) of the National Center for Health Statistics and included deaths among adults aged 35 years or older in all 50 states and the District of Columbia. Individuals were considered to be NHPI if they were reported as being Native Hawaiian, Guamanian or Chamorro, Samoan, or other Pacific Islander; NHPI adults who identified as multiracial or Hispanic were also included in primary analyses. There were a total of 4,510,183 deaths from CVD included for analysis, of which 10,870 (0.24%) deaths were among NHPI adults with a mean of 2174 deaths per year. A significant number of deaths among NHPI adults occurred below the age of 65 years (37.1%), and 57.0% of those who died were male. Single-race NHPI adults made up the majority of the population (59.5%); the largest subgroups among these persons was Native Hawaiian (14.4%), followed by Samoan (13.8%), and Guamanian or Chamorro (7.0%). The CVD ASMR among NHPI adults was 369.6 deaths per 100,000 people (95% CI, 362.4 to 376.7), which was the third highest after Black adults (558.8 deaths per 100,000 people [95% CI, 557.4 to 560.3]) and White adults (423.6 deaths per 100,000 people [95% CI, 423.2 to 424.1]). NHPI adults had a relative risk of 1.5 (95% CI, 1.5 to 1.5) for CVD death compared with Asian adults, who had a CVD ASMR of 243.9 deaths per 100,000 people (95% CI, 242.6 to 245.2). The leading cause of CVD mortality among NHPI adults was heart disease (72.6%), most commonly coronary heart disease (40.5%); a further 19.0% of CVD deaths among NHPI adults were from cerebrovascular disease. In subgroup analyses, it was found that 56.1% of CVD deaths among NHPI adults were in those who were neither Hispanic nor multiracial. These adults had a CVD ASMR of 458.5 deaths per 100,000 persons (95% CI, 446.6 to 470.4) and had a relative risk of 1.2 (95% CI, 1.2 to 1.3) for CVD death compared with NHPI adults overall. In summary, this study showed differing CVD mortality data between NHPI adults and adults of other race groups, especially Asian adults, thus underlining the importance of assessing NHPI individuals as a distinct population to achieve further health equity.

Image: PD

©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: cardiovascular diseasedisparitiesmortality
Previous Post

#VisualAbstract: Antitachycardia Pacing Prolongs Time to All-Cause Shock in Primary Prevention Patients

Next Post

#VisualAbstract Implantable Cardioverter-Defibrillator Does Not Reduce Risk of All-Cause Mortality in Chagas Cardiomyopathy

RelatedReports

Rivaroxaban likely reduces risk of recurrent stroke in specific subgroup of patients with embolic stroke of undetermined source
Cardiology

The mortality in-hospital for patients undergoing elective catheter ablation for atrial fibrillation is low

September 4, 2026
“Housing First” linked to housing stability for homeless youth with mental illness
Public Health

Mortality in the post-housing period is high among homeless people in Ottawa, Canada

August 31, 2026
Novel coronavirus identified from patients with pneumonia in Wuhan, China
Chronic Disease

Hematologic inflammatory indices may predict prognosis in younger patients with COVID-19 but not older patients

August 4, 2026
Collage of medical tech icons circling a central chip with 'AI Roundup' title and 2 Minute Medicine logo in teal background.
AI Roundup

2MM: AI Roundup: NHS England expands Microsoft Copilot nationwide, ARPA-H advances autonomous cardiovascular AI, FDA advisors back Moderna’s mRNA influenza vaccine, and UpDoc earns first clearance for a patient-facing large language model

September 3, 2026
Next Post
#VisualAbstract Implantable Cardioverter-Defibrillator Does Not Reduce Risk of All-Cause Mortality in Chagas Cardiomyopathy

#VisualAbstract Implantable Cardioverter-Defibrillator Does Not Reduce Risk of All-Cause Mortality in Chagas Cardiomyopathy

Lessons from real-world implementation of lung cancer screening

Perioperative pembrolizumab improves survival in resectable early-stage non-small cell lung cancer

Low free sugar diet reduces hepatic steatosis in nonalcoholic fatty liver disease in adolescent males

Aligos Therapeutics: ALG-055009 reduces liver fatty deposits in patients with metabolic-dysfunction associated steatohepatitis (MASH)

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Transanastomotic tubes not linked to anastomotic stricture after esophageal atresia repair
  • Artificial intelligence (AI) chatbot reduced depression, anxiety, and eating disorder risk symptoms
  • Real-time AI guidance enters live brain tumor surgery
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.